{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:36:45Z","timestamp":1792085805674,"version":"4.4.0"},"reference-count":25,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2004,8,23]],"date-time":"2004-08-23T00:00:00Z","timestamp":1093219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>Colitis is a rare but serious gastrointestinal complication associated with taxane\u2010based chemotherapy in patients with cancer. The incidence, clinical presentation, and outcome of colitis in patients with breast carcinoma treated with taxane\u2010based chemotherapy is not known.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>The authors searched their electronic database and identified patients with breast carcinoma who were treated with taxane\u2010based chemotherapy between January 1997 and December 1999. Patients diagnosed with colitis were identified and their presentation and clinical outcomes were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>During the study period, 1350 patients received taxane\u2010based chemotherapy. Sixty\u2010four patients were admitted to The University of Texas M. D. Anderson Cancer Center (Houston, TX) (73 admissions) for gastrointestinal complications. Neutropenia and\/or fever accounted for 56 of these admissions. Fourteen patients (16 admissions) were diagnosed with colitis. All had abdominal pain at median Day 6 of their chemotherapy cycle (range, 3\u20138 days), with or without other symptoms. Computed tomography scans of the abdomen and pelvis were abnormal for the 10 patients tested, whereas only 3 of the 9 patients who underwent radiographic abdominal series had abnormal findings. Two patients had a colonoscopy that confirmed the diagnosis of colitis. Blood cultures were positive in only 3 (20%) of 15 colitis events. All eight patients tested for <jats:italic>Clostridium difficile<\/jats:italic> toxin were negative. One patient died of sepsis. An autopsy subsequently revealed cecal ulceration. Two patients had bowel perforations requiring hemicolectomy. Colitis recurred in two patients after they resumed taxane\u2010based chemotherapy without dose reduction. Dose reductions prevented the recurrence of colitis in seven patients. Treatment discontinuation of taxane\u2010based chemotherapy also prevented disease recurrence.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Acute abdominal pain in patients with breast carcinoma treated with taxane\u2010based chemotherapy signaled a potentially fatal colitis, and warrants aggressive supportive care. Dose reduction or discontinuation of taxane\u2010based chemotherapy may prevent the recurrence of colitis. Cancer 2004. \u00a9 2004 American Cancer Society.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.20546","type":"journal-article","created":{"date-parts":[[2004,8,23]],"date-time":"2004-08-23T15:15:41Z","timestamp":1093274141000},"page":"1508-1513","source":"Crossref","is-referenced-by-count":28,"title":["Colitis in patients with breast carcinoma treated with taxane\u2010based chemotherapy"],"prefix":"10.1002","volume":"101","author":[{"given":"Zhiyong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuhad K.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay K.","family":"Wathen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario P.","family":"Mante Menchu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Theriault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman U.","family":"Buzdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel N.","family":"Hortobagyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,9,17]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(79)90248-1"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02554529"},{"key":"e_1_2_6_4_2","first-page":"415","article-title":"Typhlitis","volume":"42","author":"Urbach DR","year":"1999","journal-title":"Can J Surg."},{"key":"e_1_2_6_5_2","first-page":"2407","volume-title":"Cancer medicine","author":"Rolsten KVI","year":"2000"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)06195-4"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1200\/JCO.1995.13.12.2886","article-title":"Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline\u2010resistant metastatic breast cancer","volume":"13","author":"Valero V","year":"1996","journal-title":"J Clin Oncol."},{"key":"e_1_2_6_8_2","first-page":"36","article-title":"Future direction of neoadjuvant therapy for breast cancer","volume":"25","author":"Valero V","year":"1998","journal-title":"Semin Oncol."},{"key":"e_1_2_6_9_2","first-page":"29","article-title":"Taxoids: effective agents in anthracycline\u2010resistant breast cancer","volume":"22","author":"Ravdin PM","year":"1995","journal-title":"Semin Oncol."},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02074-2"},{"key":"e_1_2_6_11_2","first-page":"2359","volume-title":"Cancer medicine","author":"Sinicrope FA","year":"2000"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900215)65:4<1041::AID-CNCR2820650433>3.0.CO;2-A"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1995.1140"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1997.4842"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.3.783"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930301)71:5<1797::AID-CNCR2820710514>3.0.CO;2-B"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.3.774"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.15.1078"},{"key":"e_1_2_6_19_2","first-page":"341","article-title":"Docetaxel and vinorelbine in patients with metastatic breast cancer after using anthracycline","volume":"57","author":"Gomez\u2010Bernal A","year":"1999","journal-title":"San Antonio Breast Cancer Symp."},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026437731354"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/82.15.1247"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/83.4.288"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19890515)63:10<1944::AID-CNCR2820631013>3.0.CO;2-#"},{"key":"e_1_2_6_24_2","first-page":"1843","article-title":"The microtubule\u2010affecting drug paclitaxel has antiangiogenic activity","volume":"2","author":"Belotti D","year":"1996","journal-title":"Clin Cancer Res."},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.1999.14.31"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000901)89:5<983::AID-CNCR7>3.0.CO;2-G"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.20546","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.20546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T09:19:28Z","timestamp":1760260768000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.20546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,17]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1002\/cncr.20546"],"URL":"https:\/\/doi.org\/10.1002\/cncr.20546","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,17]]}}}